相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist
Masakuni Horiguchi et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats
M. Horiguchi et al.
PSYCHOPHARMACOLOGY (2012)
The role of serotonin receptors in the action of atypical antipsychotic drugs
H. Y. Meltzer et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
Adrian Newman-Tancredi et al.
PSYCHOPHARMACOLOGY (2011)
Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials
Matthijs W. Beltman et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
A Double-Blind, Randomized, and Placebo-Controlled Trial of Buspirone Added to Risperidone in Patients With Chronic Schizophrenia
Ali Ghaleiha et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
A Distributed Cortical Representation Underlies Crossmodal Object Recognition in Rats
Boyer D. Winters et al.
JOURNAL OF NEUROSCIENCE (2010)
Augmentation strategies for treatment-resistant depression
Andre F. Carvalho et al.
CURRENT OPINION IN PSYCHIATRY (2009)
Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist
Danijela Piskulic et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Does stimulation of 5-HT1A receptors improve cognition in schizophrenia?
Herbert Y. Meltzer et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Transcriptional regulation at a HTR1A polymorphism associated with mental illness
Brice Le Francois et al.
NEUROPHARMACOLOGY (2008)
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia:: A randomized, double-blind, placebo-controlled study
Tomiki Sumiyoshi et al.
SCHIZOPHRENIA RESEARCH (2007)
Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity:: comparison with typical and atypical conventional antipsychotics
Laurent Bardin et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
Serotonin receptors : their key role in drugs to treat schizophrenia
HY Meltzer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
How meta-analysis increases statistical power
LD Cohn et al.
PSYCHOLOGICAL METHODS (2003)
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
JG Hensler
LIFE SCIENCES (2003)
Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635
J Tauscher et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment
T Sumiyoshi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
分享论文
